undefined undefined
NaN.000
NaN.00%
COVID-19 vaccine maker Moderna (NASDAQ:MRNA) announced Thursday that its plans to build a messenger RNA vaccine plant in Kenya are on hold as it weighs future demand for mRNA vaccines in Africa. Moder...
04-11 21:24
Shares of Moderna (NASDAQ:MRNA) were up 8% in late morning trading Tuesday, the day after the biotech company released positive data from a Phase 1 study of its individualized neoantigen candidate mRN...
04-09 23:26
Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.
04-05 02:32
You may think that with a price-to-sales (or "P/S") ratio of 28.9x Arbutus Biop...
04-04 18:13
Arbutus Biopharma (NASDAQ:ABUS) quickly soared 15% after a win in a Covid vaccine patent dispute with Moderna (NASDAQ:MRNA), according to a court filing on Wednesday. Moderna fell 0.5%. The patent dec...
04-04 00:27
Shares of Roivant (NASDAQ:ROIV) rose 6% in premarket trading Tuesday after the biotech group announced a $1.5B share buyback program and released positive data for its drug brepocitinib. Roivant’s boa...
04-02 21:20
英伟达续创新高,但市场押注其看跌期权;Palantir期权成交152万张,看涨期权成交占比82.5%;纽约社区银行股价上演惊天逆转,期权成交放量超2倍>>
03-07 18:57
HC Wainwright & Co. analyst Ed Arce maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and lowers the price target from $6 to $5.
03-01 20:22
Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year.
02-29 20:36
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
02-29 18:15